Correlation Between Pasithea Therapeutics and MediciNova
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and MediciNova, you can compare the effects of market volatilities on Pasithea Therapeutics and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and MediciNova.
Diversification Opportunities for Pasithea Therapeutics and MediciNova
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pasithea and MediciNova is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and MediciNova go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and MediciNova
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the MediciNova. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 3.28 times less risky than MediciNova. The stock trades about -0.26 of its potential returns per unit of risk. The MediciNova is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 168.00 in MediciNova on September 1, 2024 and sell it today you would earn a total of 39.00 from holding MediciNova or generate 23.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. MediciNova
Performance |
| Timeline |
| Pasithea Therapeutics |
| MediciNova |
Pasithea Therapeutics and MediciNova Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and MediciNova
The main advantage of trading using opposite Pasithea Therapeutics and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
| MediciNova vs. Cue Biopharma | MediciNova vs. Tff Pharmaceuticals | MediciNova vs. Lantern Pharma | MediciNova vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |